Krsnaa Diagnostics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
May 27, 2023 at 11:12 am
Share
Krsnaa Diagnostics Limited reported earnings results for the fourth quarter and full year ended March 31, 2023. For the fourth quarter, the company reported sales was INR 1,332.26 million compared to INR 1,082.47 million a year ago. Revenue was INR 1,391.52 million compared to INR 1,123.51 million a year ago. Net income was INR 189.18 million compared to INR 179.36 million a year ago. Basic earnings per share from continuing operations was INR 6.03 compared to INR 5.4 a year ago. Diluted earnings per share from continuing operations was INR 5.88 compared to INR 5.4 a year ago.
For the full year, sales was INR 4,871.23 million compared to INR 4,554.5 million a year ago. Revenue was INR 5,065.02 million compared to INR 4,703.61 million a year ago. Net income was INR 621.11 million compared to INR 683.9 million a year ago. Basic earnings per share from continuing operations was INR 19.78 compared to INR 22.89 a year ago. Diluted earnings per share from continuing operations was INR 19.29 compared to INR 22.88 a year ago.
Krsnaa Diagnostics Limited is an India-based diagnostic services provider, both in radiology and pathology. The Company is primarily engaged in the business of providing diagnostic services all over India. The Company is providing radiology and pathology services for X-Ray, computed tomography (CT) scan, magnetic resonance imaging (MRI), mammography, tele- reporting services, and all types of blood and urine investigation. Its technology helps health care professionals diagnose and treat medical problems by imaging the interior of the human body. Its lab services offerings encompass a range of investigations from routine tests to specialized ones. Its health packages include Ayaksham-Total, Bone Health-Advance, Fever Profile-Basic, Hypertension Profile, Menopause Profile-Advance, and Polycystic Ovaries Screening (PCOS), among others. The Company offers its services to public and private hospitals, medical colleges, and community health centers.